Ralfkiaer E, Bosq J, Gatter K C, Schwarting R, Gerdes J, Stein H, Mason D Y
Arch Dermatol Res. 1987;279(5):285-92. doi: 10.1007/BF00431219.
Skin biopsy specimens from normal skin and from 115 patients with benign dermatoses, pre- or pseudo-malignant disorders or malignant cutaneous lymphomas have been examined immunohistologically for expression of the Reed-Sternberg cell associated antigen CD30 detected by monoclonal antibodies Ki-1 and Ber-H2. The antibodies stained the atypical cells in lymphomatoid papulosis, a proportion of the neoplastic cells in some cases of mycosis fungoides and most of the neoplastic cells in six large cell anaplastic/pleomorphic non-Hodgkin's lymphomas. The lymphoid cells in all other specimens were Ki-1- and Ber-H2-negative. In all cases, expression of the Ki-1/Ber-H2 antigen was accompanied by expression of activation and proliferation associated markers (i.e., HLA-DR, IL-2 receptor, transferrin receptor and the Ki-67 nuclear antigen). These data indicate the value of antibodies Ki-1 and Ber-H2 in distinguishing between lymphomatoid papulosis and other types of pre- or pseudo-malignant disorders and support the view that lymphomatoid papulosis, Hodgkin's disease and some types of non-Hodgkin's lymphoma constitute a spectrum of related disorders, originated from activated lymphoid cells.
对取自正常皮肤以及115例患有良性皮肤病、癌前或准恶性疾病或恶性皮肤淋巴瘤患者的皮肤活检标本进行了免疫组织学检查,以检测由单克隆抗体Ki-1和Ber-H2所识别的里德-施特恩贝格细胞相关抗原CD30的表达情况。这些抗体对淋巴瘤样丘疹病中的非典型细胞、蕈样肉芽肿某些病例中的一部分肿瘤细胞以及6例大细胞间变性/多形性非霍奇金淋巴瘤中的大多数肿瘤细胞进行了染色。所有其他标本中的淋巴细胞Ki-1和Ber-H2均呈阴性。在所有病例中,Ki-1/Ber-H2抗原的表达都伴随着激活和增殖相关标志物(即HLA-DR、IL-2受体、转铁蛋白受体和Ki-67核抗原)的表达。这些数据表明抗体Ki-1和Ber-H2在区分淋巴瘤样丘疹病与其他类型的癌前或准恶性疾病方面具有价值,并支持这样一种观点,即淋巴瘤样丘疹病、霍奇金病和某些类型的非霍奇金淋巴瘤构成了一系列相关疾病,起源于活化的淋巴细胞。